Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | IL | 21 Nov 2016 | |
Inflammation | Preclinical | CH | 21 Nov 2016 | |
Xerophthalmia | Preclinical | IL | 21 Nov 2016 | |
Xerophthalmia | Preclinical | CH | 21 Nov 2016 | |
Dry Eye Syndromes | Preclinical | IL | - | |
Dry Eye Syndromes | Preclinical | IL | - |